Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
News
All NewsCompaniesIndexesCurrency / ForexCommoditiesCryptocurrenciesETFInterest RatesEconomyThemesSectors 

U.S. secures 3.2 million doses of Novavax COVID vaccine

07/11/2022 | 08:30am EST
FILE PHOTO: Germany starts vaccinating with Novavax

(Reuters) - The U.S. government has secured 3.2 million doses of COVID-19 vaccine developed by Novavax Inc, the Department of Health and Human Services (HHS) and the company said.

The vaccine has not yet been authorized for emergency use by the U.S. Food and Drug Administration (FDA). Advisers to agency last month voted to recommend that the FDA authorize the shot for use in adults.

Novavax is expected to complete all necessary quality testing in the next few weeks, which would support final release of the shots, HHS said.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli)


ę Reuters 2022
Latest news "Economy"
12:35pFed's Cook says time nearing to hike rates in smaller steps
RE
12:34pDow dips ahead of Powell speech; Nasdaq kept afloat by growth stocks
RE
12:34pYellen says U.S. firms should be mindful of China-Taiwan geopolitical risks
RE
12:30pVatican website down in suspected hacker attack
RE
12:30pRide-hailing app Cabify to invest $300 mln through 2024 to strengthen Latam presence
RE
12:29pDistant black hole is caught in the act of annihilating a star
RE
12:28pREUTERS NEXT-BHP's CEO expects Chinese economic growth to continue
RE
12:22pJuventus has no requirement of additional capital, says Exor's Elkann
RE
12:22pEU defends gas price cap proposal after country criticism
RE
12:20pOPEC oil output drops in November after cut pledged -survey
RE
Latest news "Economy"